Bystritsky A, Fogelson D, Doctor R, Yager J
UCLA Neuropsychiatric Institute and Hospital, Los Angeles; Pacific Psychopharmacology Research Institute, Santa Monica; and California State University at Northridge, California.
J Psychother Pract Res. 1993 Spring;2(2):164-70.
Patients with screening diagnoses of DSM-III-R anxiety disorders were surveyed in two clinics, one oriented toward pharmacology, the other toward behavior therapy. Patients in the two clinics were similar on demographic, diagnostic, and treatment variables but dissimilar on severity and composition of symptoms and on the use of medications and medical services. Patients seen in the psychopharmacology clinic reported more physical symptoms and more frequent use of prescription and over-the-counter medications. Patients in the behavior therapy clinic reported more phobic symptoms. Findings may reflect self-selection and/or referral biases toward one or the other type of clinic based on differences in initial symptoms, beliefs in their pathogenesis, and other associated variables. Further study at point of entry and at follow-up may help clarify these differences.
对筛查诊断为DSM-III-R焦虑症的患者在两家诊所进行了调查,一家侧重于药理学,另一家侧重于行为疗法。两家诊所的患者在人口统计学、诊断和治疗变量方面相似,但在症状的严重程度和构成以及药物和医疗服务的使用方面存在差异。在精神药理学诊所就诊的患者报告有更多的身体症状,并且更频繁地使用处方药和非处方药。行为疗法诊所的患者报告有更多的恐惧症状。研究结果可能反映了基于初始症状差异、对其发病机制的信念以及其他相关变量,患者对一种或另一种类型诊所的自我选择和/或转诊偏倚。在就诊时和随访时进行进一步研究可能有助于阐明这些差异。